Alkem Laboratories · NSE: ALKEM · BSE: 539523
Q1 FY24 results · Apr–Jun 2023
Alkem Laboratories reported revenue from operations of ₹2,967.72 crore (up 15.2% from Q1 FY23) and net profit of ₹287.81 crore (up 119.0% from Q1 FY23) for Q1 FY24 (Apr–Jun 2023), on a consolidated basis.
| Item | Q1 FY24 | Q1 FY23 | YoY | Q4 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 2,967.72 | 2,576.38 | +15.2% | 2,902.60 | +2.2% |
| Other income | 65.84 | 51.41 | +28.1% | 68.67 | −4.1% |
| Total income | 3,033.56 | 2,627.79 | +15.4% | 2,971.27 | +2.1% |
| Profit before tax | 352.85 | 151.89 | +132.3% | 211.66 | +66.7% |
| Net profit for the period | 287.81 | 131.45 | +119.0% | 67.68 | +325.3% |
| Attributable to shareholders of the company | 286.73 | 127.64 | +124.6% | 70.98 | +304.0% |
| EPS, basic (₹) | 23.98 | 10.68 | +124.6% | 5.94 | +303.9% |
| Net margin (%) | 9.7 | 5.1 | 2.3 |
| Item | Q1 FY24 | Q1 FY23 | YoY | Q4 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 2,253.17 | 2,058.35 | +9.5% | 2,237.99 | +0.7% |
| Other income | 64.70 | 55.31 | +17.0% | 76.60 | −15.5% |
| Total income | 2,317.87 | 2,113.66 | +9.7% | 2,314.59 | +0.1% |
| Profit before tax | 318.92 | 159.79 | +99.6% | 329.69 | −3.3% |
| Net profit for the period | 271.44 | 140.10 | +93.7% | 254.79 | +6.5% |
| EPS, basic (₹) | 22.70 | 11.72 | +93.8% | 21.31 | +6.5% |
| Net margin (%) | 12.0 | 6.8 | 11.4 |
Consolidated
- Filed with BSE
- 10 Aug 2023, 16:04 IST
- Board meeting
- 10 Aug 2023
- Period
- 01 Apr 2023 to 30 Jun 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 10 Aug 2023, 16:04 IST
- Board meeting
- 10 Aug 2023
- Period
- 01 Apr 2023 to 30 Jun 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE